Nexans (ENXTPA:NEX) has been quietly rewarding patient shareholders, with the stock up about 26% this year and roughly 65% over the past 3 years, despite recent revenue and earnings dips. See our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback